VERSES AI Inc. (CBOE:VERS) (OTCQB:VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation intelligent systems, announces milestones for the year end update ...

Obi-Martin Signs Professional Contract and Sets Record at Man UtdManchester United’s highly-rated academy talent, Chido ...

The Phase 1 trial ANQUR, now testing two new doses of the ALS therapy QRL-201, is enrolling patients at 12 sites in Canada and across Europe.